Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cells

被引:21
|
作者
Sun, Wenjing [1 ]
Quan, Chao [1 ]
Huang, Yun [1 ]
Ji, Wei [1 ]
Yu, Lisa [1 ]
Li, Xinxin [1 ]
Zhang, Yang [1 ]
Zheng, Zhibo [1 ]
Zou, Hongyan [1 ]
Li, Quanxiao [1 ]
Xu, Ping [3 ]
Feng, Yan [4 ]
Li, Li [5 ]
Zhang, Yunyan [6 ]
Cui, Yunfu [7 ]
Jia, Xueyuan [1 ]
Meng, Xiangning [1 ]
Zhang, Chunyu [1 ]
Jin, Yan [1 ,2 ]
Bai, Jing [1 ]
Yu, Jingcui [8 ]
Yu, Yang [1 ]
Yang, Jianhua [9 ]
Fu, Songbin [1 ,2 ]
机构
[1] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China
[2] Harbin Med Univ, Heilongjiang Higher Educ Inst, Key Lab Med Genet, Harbin, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Haematol, Harbin, Peoples R China
[4] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China
[5] Harbin Med Univ, Affiliated Hosp 3, Div Colorectal Surg, Harbin, Peoples R China
[6] Harbin Med Univ, Affiliated Hosp 3, Dept Gynaecol, Harbin, Peoples R China
[7] Harbin Med Univ, Affiliated Hosp 1, Dept Hepatopancreatobiliary Surg, Harbin, Peoples R China
[8] Harbin Med Univ, Affiliated Hosp 1, Ctr Sci Res, Harbin, Peoples R China
[9] Baylor Coll Med, Dept Pediat, Texas Childrens Canc Ctr, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
来源
JOURNAL OF PATHOLOGY | 2015年 / 235卷 / 01期
基金
中国国家自然科学基金;
关键词
double minute chromosomes; malignant tumour; MAPK signalling pathway; ERK1/2 constitutive phosphorylation; DAVID BIOINFORMATICS RESOURCES; LARGE GENE LISTS; GENOMIC INSTABILITY; MYELOID-LEUKEMIA; OVARIAN-CANCER; MAP KINASES; FUSION GENE; MYC GENES; AMPLIFICATION; MECHANISMS;
D O I
10.1002/path.4439
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Double minute chromosomes (DMs) are extrachromosomal cytogenetic structures found in tumour cells. As hallmarks of gene amplification, DMs often carry oncogenes and drug-resistance genes and play important roles in malignant tumour progression and drug resistance. The mitogen-activated protein kinase (MAPK) signalling pathway is frequently dysregulated in human malignant tumours, which induces genomic instability, but it remains unclear whether a close relationship exists between MAPK signalling and DMs. In the present study, we focused on three major components of MAPK signalling, ERK1/2, JNK1/2/3 and p38, to investigate the relationship between MAPK and DM production in tumour cells. We found that the constitutive phosphorylation of ERK1/2, but not JNK1/2/3 and p38, was closely associated with DMs in tumour cells. Inhibition of ERK1/2 activation in DM-containing and ERK1/2 constitutively phosphorylated tumour cells was able to markedly decrease the number of DMs, as well as the degree of amplification and expression of DM-carried genes. The mechanism was found to be an increasing tendency of DM DNA to break, become enveloped into micronuclei (MNs) and excluded from the tumour cells during the S/G(2) phases of the cell cycle, events that accompanied the reversion of malignant behaviour. Our study reveals a linkage between ERK1/2 activation and DM stability in tumour cells. (c) 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
引用
收藏
页码:14 / 24
页数:11
相关论文
共 50 条
  • [1] Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent
    Barry, OP
    Mullan, B
    Sheehan, D
    Kazanietz, MG
    Shanahan, F
    Collins, JK
    O'Sullivan, GC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) : 15537 - 15546
  • [2] ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
    Zheng, Chunning
    Jiao, Xuelong
    Jiang, Yingsheng
    Sun, Shaochuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (02) : 300 - 306
  • [3] Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation
    Silvany, RE
    Eliazer, S
    Wolff, NC
    Ilaria, RL
    ONCOGENE, 2000, 19 (39) : 4523 - 4530
  • [4] Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation
    Robert E Silvany
    Susan Eliazer
    Nicholas C Wolff
    Robert L Ilaria
    Oncogene, 2000, 19 : 4523 - 4530
  • [5] Activation of ERK1/ERK2 phosphorylation by ATP in bovine chromaffin cells
    Hexum, Terry
    Luke, Toni
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 406 - 406
  • [6] Upregulation of ADP-ribosylation factor 1 contributes to the enhanced activation of the MAPK ERK1/2 in prostate cancer cells
    Davis, Jason
    Teng, Yong
    Guo, Jianhui
    Wu, Guangyu
    FASEB JOURNAL, 2014, 28 (01):
  • [7] TRAIL: Activation of ERK1/2 protects cells against apoptosis
    Cremer, M
    CANCER INVESTIGATION, 2005, 23 (07) : 651 - 651
  • [8] Phosphatase deficiency causes constitutive phosphorylation of ERK1/2 in THP-1 cells
    Lu, YB
    Wahl, LM
    FASEB JOURNAL, 2006, 20 (05): : A923 - A924
  • [9] Fer kinase sustains the activation level of ERK1/2 and increases the production of VEGF in hypoxic cells
    Salem, Y
    Shpungin, S
    Pasder, O
    Pomp, O
    Taler, M
    Malovani, H
    Nir, U
    CELLULAR SIGNALLING, 2005, 17 (03) : 341 - 353
  • [10] Activation of spinal ERK1/2 contributes to mechanical allodynia in a rat model of postoperative pain
    Shi, Xu-Dan
    Fu, Di
    Xu, Jun-Mei
    Zhang, Yan-Ling
    Dai, Ru-Ping
    MOLECULAR MEDICINE REPORTS, 2013, 7 (05) : 1661 - 1665